nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—Vestibular disorder—Riluzole—amyotrophic lateral sclerosis	0.0273	0.0402	CcSEcCtD
Zopiclone—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0231	CcSEcCtD
Zopiclone—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0217	CcSEcCtD
Zopiclone—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0212	CcSEcCtD
Zopiclone—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0212	CcSEcCtD
Zopiclone—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.019	CcSEcCtD
Zopiclone—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0128	0.0789	CbGeAlD
Zopiclone—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0172	CcSEcCtD
Zopiclone—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0165	CcSEcCtD
Zopiclone—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.011	0.0162	CcSEcCtD
Zopiclone—TSPO—appendage—amyotrophic lateral sclerosis	0.011	0.0677	CbGeAlD
Zopiclone—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0154	CcSEcCtD
Zopiclone—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0154	CcSEcCtD
Zopiclone—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00991	0.0146	CcSEcCtD
Zopiclone—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00944	0.0139	CcSEcCtD
Zopiclone—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00873	0.0128	CcSEcCtD
Zopiclone—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00838	0.0123	CcSEcCtD
Zopiclone—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00813	0.012	CcSEcCtD
Zopiclone—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00783	0.0115	CcSEcCtD
Zopiclone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00775	0.0114	CcSEcCtD
Zopiclone—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00768	0.0113	CcSEcCtD
Zopiclone—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00768	0.0113	CcSEcCtD
Zopiclone—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00761	0.0112	CcSEcCtD
Zopiclone—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00761	0.0112	CcSEcCtD
Zopiclone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00735	0.0108	CcSEcCtD
Zopiclone—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00735	0.0108	CcSEcCtD
Zopiclone—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00711	0.0105	CcSEcCtD
Zopiclone—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00688	0.0425	CbGeAlD
Zopiclone—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00683	0.01	CcSEcCtD
Zopiclone—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00652	0.00959	CcSEcCtD
Zopiclone—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00638	0.00939	CcSEcCtD
Zopiclone—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00629	0.00925	CcSEcCtD
Zopiclone—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00629	0.0388	CbGeAlD
Zopiclone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00919	CcSEcCtD
Zopiclone—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00912	CcSEcCtD
Zopiclone—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00612	0.009	CcSEcCtD
Zopiclone—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00608	0.0375	CbGeAlD
Zopiclone—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00888	CcSEcCtD
Zopiclone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00888	CcSEcCtD
Zopiclone—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.006	0.00882	CcSEcCtD
Zopiclone—Gout—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00865	CcSEcCtD
Zopiclone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0058	0.00854	CcSEcCtD
Zopiclone—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00827	CcSEcCtD
Zopiclone—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00822	CcSEcCtD
Zopiclone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00807	CcSEcCtD
Zopiclone—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00807	CcSEcCtD
Zopiclone—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00798	CcSEcCtD
Zopiclone—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00798	CcSEcCtD
Zopiclone—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00789	CcSEcCtD
Zopiclone—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0078	CcSEcCtD
Zopiclone—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0078	CcSEcCtD
Zopiclone—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00758	CcSEcCtD
Zopiclone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00742	CcSEcCtD
Zopiclone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00708	CcSEcCtD
Zopiclone—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00701	CcSEcCtD
Zopiclone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00694	CcSEcCtD
Zopiclone—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00687	CcSEcCtD
Zopiclone—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00687	CcSEcCtD
Zopiclone—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00667	CcSEcCtD
Zopiclone—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00652	CcSEcCtD
Zopiclone—Injury—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00638	CcSEcCtD
Zopiclone—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00632	CcSEcCtD
Zopiclone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00624	CcSEcCtD
Zopiclone—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00624	CcSEcCtD
Zopiclone—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00616	CcSEcCtD
Zopiclone—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00603	CcSEcCtD
Zopiclone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00586	CcSEcCtD
Zopiclone—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00586	CcSEcCtD
Zopiclone—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00581	CcSEcCtD
Zopiclone—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00394	0.0244	CbGeAlD
Zopiclone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00577	CcSEcCtD
Zopiclone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00577	CcSEcCtD
Zopiclone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00566	CcSEcCtD
Zopiclone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00555	CcSEcCtD
Zopiclone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00551	CcSEcCtD
Zopiclone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00545	CcSEcCtD
Zopiclone—TSPO—embryo—amyotrophic lateral sclerosis	0.00364	0.0225	CbGeAlD
Zopiclone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00533	CcSEcCtD
Zopiclone—GABRA2—brainstem—amyotrophic lateral sclerosis	0.0036	0.0222	CbGeAlD
Zopiclone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00528	CcSEcCtD
Zopiclone—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00354	0.0219	CbGeAlD
Zopiclone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00519	CcSEcCtD
Zopiclone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00517	CcSEcCtD
Zopiclone—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00348	0.0215	CbGeAlD
Zopiclone—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00507	CcSEcCtD
Zopiclone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00507	CcSEcCtD
Zopiclone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00507	CcSEcCtD
Zopiclone—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00341	0.0211	CbGeAlD
Zopiclone—TSPO—brainstem—amyotrophic lateral sclerosis	0.00334	0.0206	CbGeAlD
Zopiclone—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00487	CcSEcCtD
Zopiclone—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00474	CcSEcCtD
Zopiclone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00468	CcSEcCtD
Zopiclone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00467	CcSEcCtD
Zopiclone—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00462	CcSEcCtD
Zopiclone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00461	CcSEcCtD
Zopiclone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00458	CcSEcCtD
Zopiclone—Depression—Riluzole—amyotrophic lateral sclerosis	0.00306	0.0045	CcSEcCtD
Zopiclone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00443	CcSEcCtD
Zopiclone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0044	CcSEcCtD
Zopiclone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00439	CcSEcCtD
Zopiclone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00433	CcSEcCtD
Zopiclone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00431	CcSEcCtD
Zopiclone—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00426	CcSEcCtD
Zopiclone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00406	CcSEcCtD
Zopiclone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00405	CcSEcCtD
Zopiclone—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00275	0.017	CbGeAlD
Zopiclone—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00275	0.017	CbGeAlD
Zopiclone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00403	CcSEcCtD
Zopiclone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00403	CcSEcCtD
Zopiclone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00402	CcSEcCtD
Zopiclone—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00272	0.0168	CbGeAlD
Zopiclone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00399	CcSEcCtD
Zopiclone—GABRG3—brain—amyotrophic lateral sclerosis	0.00271	0.0167	CbGeAlD
Zopiclone—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00262	0.0162	CbGeAlD
Zopiclone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00383	CcSEcCtD
Zopiclone—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00253	0.0157	CbGeAlD
Zopiclone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00364	CcSEcCtD
Zopiclone—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00245	0.0151	CbGeAlD
Zopiclone—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00245	0.0151	CbGeAlD
Zopiclone—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00244	0.0151	CbGeAlD
Zopiclone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00358	CcSEcCtD
Zopiclone—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00243	0.015	CbGeAlD
Zopiclone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00346	CcSEcCtD
Zopiclone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00346	CcSEcCtD
Zopiclone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00343	CcSEcCtD
Zopiclone—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.00233	0.0144	CbGeAlD
Zopiclone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00341	CcSEcCtD
Zopiclone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00339	CcSEcCtD
Zopiclone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00331	CcSEcCtD
Zopiclone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00327	CcSEcCtD
Zopiclone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00326	CcSEcCtD
Zopiclone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00324	CcSEcCtD
Zopiclone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00322	CcSEcCtD
Zopiclone—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00217	0.0134	CbGeAlD
Zopiclone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00318	CcSEcCtD
Zopiclone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00317	CcSEcCtD
Zopiclone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00312	CcSEcCtD
Zopiclone—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00211	0.013	CbGeAlD
Zopiclone—GABRA5—brain—amyotrophic lateral sclerosis	0.00208	0.0129	CbGeAlD
Zopiclone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00306	CcSEcCtD
Zopiclone—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00207	0.0128	CbGeAlD
Zopiclone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00305	CcSEcCtD
Zopiclone—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00207	0.0128	CbGeAlD
Zopiclone—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00207	0.0128	CbGeAlD
Zopiclone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00204	0.003	CcSEcCtD
Zopiclone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00204	0.003	CcSEcCtD
Zopiclone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00299	CcSEcCtD
Zopiclone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00297	CcSEcCtD
Zopiclone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.002	0.00294	CcSEcCtD
Zopiclone—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00199	0.0123	CbGeAlD
Zopiclone—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00199	0.0123	CbGeAlD
Zopiclone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0029	CcSEcCtD
Zopiclone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00288	CcSEcCtD
Zopiclone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00286	CcSEcCtD
Zopiclone—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00194	0.012	CbGeAlD
Zopiclone—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00194	0.012	CbGeAlD
Zopiclone—GABRA3—brain—amyotrophic lateral sclerosis	0.00194	0.012	CbGeAlD
Zopiclone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00281	CcSEcCtD
Zopiclone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00278	CcSEcCtD
Zopiclone—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00189	0.0117	CbGeAlD
Zopiclone—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00188	0.0116	CbGeAlD
Zopiclone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00275	CcSEcCtD
Zopiclone—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00182	0.0113	CbGeAlD
Zopiclone—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00182	0.0112	CbGeAlD
Zopiclone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00262	CcSEcCtD
Zopiclone—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00178	0.011	CbGeAlD
Zopiclone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00261	CcSEcCtD
Zopiclone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00259	CcSEcCtD
Zopiclone—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00176	0.0108	CbGeAlD
Zopiclone—TSPO—nervous system—amyotrophic lateral sclerosis	0.00175	0.0108	CbGeAlD
Zopiclone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00257	CcSEcCtD
Zopiclone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00256	CcSEcCtD
Zopiclone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00254	CcSEcCtD
Zopiclone—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00172	0.0106	CbGeAlD
Zopiclone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0025	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00249	CcSEcCtD
Zopiclone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00248	CcSEcCtD
Zopiclone—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00168	0.0104	CbGeAlD
Zopiclone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00246	CcSEcCtD
Zopiclone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00246	CcSEcCtD
Zopiclone—TSPO—cerebellum—amyotrophic lateral sclerosis	0.00164	0.0102	CbGeAlD
Zopiclone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00237	CcSEcCtD
Zopiclone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00236	CcSEcCtD
Zopiclone—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00159	0.0098	CbGeAlD
Zopiclone—GABRG2—brain—amyotrophic lateral sclerosis	0.00158	0.00975	CbGeAlD
Zopiclone—GABRB2—brain—amyotrophic lateral sclerosis	0.00158	0.00975	CbGeAlD
Zopiclone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00229	CcSEcCtD
Zopiclone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00228	CcSEcCtD
Zopiclone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00228	CcSEcCtD
Zopiclone—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00153	0.00943	CbGeAlD
Zopiclone—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00149	0.00922	CbGeAlD
Zopiclone—GABRA2—brain—amyotrophic lateral sclerosis	0.00144	0.00891	CbGeAlD
Zopiclone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00212	CcSEcCtD
Zopiclone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00207	CcSEcCtD
Zopiclone—GABRA1—brain—amyotrophic lateral sclerosis	0.00139	0.00861	CbGeAlD
Zopiclone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00204	CcSEcCtD
Zopiclone—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00134	0.0083	CbGeAlD
Zopiclone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00197	CcSEcCtD
Zopiclone—TSPO—brain—amyotrophic lateral sclerosis	0.00134	0.00825	CbGeAlD
Zopiclone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0019	CcSEcCtD
Zopiclone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00183	CcSEcCtD
Zopiclone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00182	CcSEcCtD
Zopiclone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00181	CcSEcCtD
Zopiclone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0018	CcSEcCtD
Zopiclone—GABRB3—brain—amyotrophic lateral sclerosis	0.00121	0.00749	CbGeAlD
Zopiclone—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.0012	0.0074	CbGeAlD
Zopiclone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00171	CcSEcCtD
Zopiclone—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00115	0.00713	CbGeAlD
Zopiclone—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00101	0.00623	CbGeAlD
Zopiclone—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000973	0.00601	CbGeAlD
Zopiclone—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000972	0.006	CbGeAlD
Zopiclone—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00095	0.00587	CbGeAlD
Zopiclone—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000936	0.00578	CbGeAlD
Zopiclone—CYP2C8—brain—amyotrophic lateral sclerosis	0.000917	0.00566	CbGeAlD
Zopiclone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000812	0.00502	CbGeAlD
Zopiclone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000782	0.00483	CbGeAlD
Zopiclone—CYP2E1—brain—amyotrophic lateral sclerosis	0.000772	0.00476	CbGeAlD
Zopiclone—PTGS1—brain—amyotrophic lateral sclerosis	0.000743	0.00459	CbGeAlD
Zopiclone—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000638	0.00403	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000635	0.00401	CbGpPWpGaD
Zopiclone—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000632	0.004	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000628	0.00397	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000625	0.00395	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000625	0.00395	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000619	0.00392	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000608	0.00384	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000599	0.00379	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000598	0.00378	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000594	0.00375	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000593	0.00375	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000593	0.00375	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000583	0.00369	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000582	0.00368	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00058	0.00367	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000578	0.00365	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000578	0.00365	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000578	0.00365	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000577	0.00365	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000576	0.00364	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000576	0.00364	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000572	0.00361	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000566	0.00357	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000566	0.00357	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000562	0.00355	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000558	0.00353	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000557	0.00352	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000556	0.00351	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000556	0.00351	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000553	0.0035	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000552	0.00349	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000552	0.00349	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000548	0.00346	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000542	0.00343	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000542	0.00343	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00054	0.00341	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00054	0.00341	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000537	0.0034	CbGpPWpGaD
Zopiclone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000536	0.00339	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000534	0.00338	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000529	0.00335	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000528	0.00334	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000528	0.00334	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000519	0.00328	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000519	0.00328	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000515	0.00326	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000513	0.00324	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00051	0.00322	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00051	0.00322	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000506	0.0032	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000504	0.00319	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000501	0.00317	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000498	0.00314	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000495	0.00313	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000493	0.00312	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000492	0.00311	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000489	0.00309	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000489	0.00309	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000483	0.00305	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000481	0.00304	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000479	0.00303	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000475	0.003	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000474	0.003	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000474	0.003	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000466	0.00295	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000458	0.0029	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000455	0.00288	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000454	0.00287	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000454	0.00287	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000449	0.00284	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000447	0.00282	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000446	0.00282	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000442	0.00279	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000441	0.00279	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000441	0.00279	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000441	0.00279	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000433	0.00274	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000433	0.00274	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000433	0.00274	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000428	0.0027	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000427	0.0027	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000426	0.00269	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000426	0.00269	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000425	0.00269	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000423	0.00267	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000423	0.00267	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000422	0.00267	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000418	0.00264	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000415	0.00263	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000415	0.00263	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000415	0.00262	CbGpPWpGaD
Zopiclone—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000408	0.00258	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000408	0.00258	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000405	0.00256	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000403	0.00255	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000393	0.00249	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000391	0.00247	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000386	0.00244	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00038	0.0024	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000377	0.00238	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000375	0.00237	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000371	0.00235	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00037	0.00234	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00037	0.00234	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000363	0.0023	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000363	0.0023	CbGpPWpGaD
Zopiclone—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000357	0.00225	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000356	0.00225	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000352	0.00223	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000341	0.00216	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000332	0.0021	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000324	0.00205	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000301	0.0019	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000299	0.00189	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00029	0.00183	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00029	0.00183	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000287	0.00182	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000285	0.0018	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000279	0.00176	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000274	0.00173	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000269	0.0017	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000267	0.00169	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000263	0.00166	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00026	0.00165	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000259	0.00163	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000256	0.00162	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000244	0.00154	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000244	0.00154	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000242	0.00153	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000241	0.00153	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000237	0.0015	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000237	0.0015	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000233	0.00147	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000233	0.00147	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000232	0.00146	CbGpPWpGaD
Zopiclone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00023	0.00146	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00023	0.00145	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000229	0.00145	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000229	0.00145	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000228	0.00144	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000227	0.00144	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000227	0.00144	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000227	0.00143	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000223	0.00141	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000223	0.00141	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000218	0.00138	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000212	0.00134	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000211	0.00134	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000208	0.00131	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000204	0.00129	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000203	0.00128	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000199	0.00126	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000198	0.00125	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000197	0.00125	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000196	0.00124	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000196	0.00124	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000195	0.00123	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000195	0.00123	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000191	0.00121	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000189	0.00119	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000187	0.00118	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000186	0.00117	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000185	0.00117	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000183	0.00116	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00018	0.00113	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000174	0.0011	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000167	0.00105	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000165	0.00105	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000163	0.00103	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000157	0.000992	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000156	0.000986	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000149	0.000944	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000147	0.000927	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000147	0.000927	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000142	0.000897	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000135	0.000851	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000134	0.000848	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000133	0.000839	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000127	0.000802	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000127	0.000801	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000127	0.000801	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000127	0.000801	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000125	0.000788	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000118	0.000747	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000117	0.000741	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000116	0.000733	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000108	0.000681	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000108	0.00068	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000106	0.00067	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000103	0.000652	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000103	0.000652	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000101	0.000641	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	9.92e-05	0.000627	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.62e-05	0.000608	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	9.44e-05	0.000596	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	9.17e-05	0.000579	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.04e-05	0.000571	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.88e-05	0.000561	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.77e-05	0.000555	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.76e-05	0.000554	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.25e-05	0.000521	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.15e-05	0.000515	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.04e-05	0.000508	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.46e-05	0.000471	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.44e-05	0.00047	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	7.42e-05	0.000469	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	6.95e-05	0.000439	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.8e-05	0.00043	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.8e-05	0.00043	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	6.41e-05	0.000405	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.22e-05	0.000393	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.09e-05	0.000385	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.84e-05	0.000369	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.79e-05	0.000366	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.65e-05	0.000357	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.44e-05	0.000344	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	5.26e-05	0.000333	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.22e-05	0.00033	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.1e-05	0.000322	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.92e-05	0.000311	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.8e-05	0.000304	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.75e-05	0.0003	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.38e-05	0.000277	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.28e-05	0.000271	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.03e-05	0.000254	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.91e-05	0.000247	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.73e-05	0.000236	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.44e-05	0.000217	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	3.31e-05	0.000209	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.29e-05	0.000208	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.27e-05	0.000207	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.01e-05	0.00019	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.83e-05	0.000179	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.83e-05	0.000179	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.68e-05	0.000169	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.6e-05	0.000164	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.47e-05	0.000156	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.3e-05	0.000146	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.27e-05	0.000143	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.14e-05	0.000135	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.12e-05	0.000134	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.74e-05	0.00011	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.7e-05	0.000107	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.52e-05	9.6e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-05	9.26e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	8.82e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.19e-05	7.54e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.15e-05	7.26e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.87e-06	4.97e-05	CbGpPWpGaD
